wAIHA
Showing 1 - 23 of 23
Anemia, Hemolytic, Autoimmune Trial (Nipocalimab)
Temporarily not available
- Warm Autoimmune Hemolytic Anemia
- (no location specified)
Nov 15, 2022
Warm Autoimmune Hemolytic Anemia (wAIHA) Trial in Singapore (Ianalumab, Placebo)
Recruiting
- Warm Autoimmune Hemolytic Anemia (wAIHA)
- Ianalumab
- Placebo
-
Singapore, SingaporeNovartis Investigative Site
Jan 5, 2023
Warm Autoimmune Hemolytic Anemia Trial in Beijing (Sirolimus)
Not yet recruiting
- Warm Autoimmune Hemolytic Anemia
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 21, 2023
Warm Autoimmune Hemolytic Anemia Trial in Beijing (Zanubrutinib)
Not yet recruiting
- Warm Autoimmune Hemolytic Anemia
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 20, 2023
Warm Autoimmune Hemolytic Anemia (wAIHA) Trial in Worldwide (rilzabrutinib)
Recruiting
- Warm Autoimmune Hemolytic Anemia (wAIHA)
-
Washington, District of Columbia
- +12 more
Oct 28, 2022
Warm Autoimmune Hemolytic Anemia (wAIHA) Trial in Worldwide (Isatuximab SAR650984)
Recruiting
- Warm Autoimmune Hemolytic Anemia (wAIHA)
- Isatuximab SAR650984
-
Los Angeles, California
- +8 more
Mar 16, 2022
Warm Autoimmune Hemolytic Anemia Trial in Riverside (ALXN1830, Placebo)
Withdrawn
- Warm Autoimmune Hemolytic Anemia
- ALXN1830
- Placebo
-
Riverside, CaliforniaClinical Study Site
Feb 2, 2022
Bullous Pemphigoid (BP), Cold Agglutinin Disease (CAD), Warm Autoimmune Hemolytic Anemia (WAIHA) Trial in Vienna (BIV009,
Completed
- Bullous Pemphigoid (BP)
- +3 more
- BIV009
- Placebo
-
Vienna, AustriaMedical University of Vienna
Apr 21, 2022
Warm Autoimmune Hemolytic Anemia, Cold Agglutinin Disease Trial in United States (APL-2)
Active, not recruiting
- Warm Autoimmune Hemolytic Anemia
- Cold Agglutinin Disease
-
Whittier, California
- +7 more
Nov 20, 2020
Warm Autoimmune Hemolytic Anemia Trial in Worldwide (RVT-1401 680 mg/weekly, RVT-1401 340 mg/weekly)
Terminated
- Warm Autoimmune Hemolytic Anemia
- RVT-1401 680 mg/weekly
- RVT-1401 340 mg/weekly
-
Iowa City, Iowa
- +20 more
Jul 1, 2022
Warm Autoimmune Hemolytic Anemia (wAIHA) Trial in Worldwide (parsaclisinib, )
Recruiting
- Warm Autoimmune Hemolytic Anemia (wAIHA)
- parsaclisinib
- placebo
-
Los Angeles, California
- +52 more
Nov 15, 2022
Warm Autoimmune Hemolytic Anemia Trial (Obexelimab, Placebo)
Not yet recruiting
- Warm Autoimmune Hemolytic Anemia
- Obexelimab
- Placebo
- (no location specified)
Mar 24, 2023
Warm Autoimmune Hemolytic Anemia Trial in Jordan, United States (ALXN1830)
Terminated
- Warm Autoimmune Hemolytic Anemia
-
Los Angeles, California
- +9 more
May 1, 2020
Warm Antibody Autoimmune Hemolytic Anemia Trial (HMPL-523(300mg PO QD), Placebo)
Not yet recruiting
- Warm Antibody Autoimmune Hemolytic Anemia
- HMPL-523(300mg PO QD)
- Placebo
- (no location specified)
Sep 7, 2022
Warm Antibody Autoimmune Hemolytic Anemia Trial in Worldwide (Fostamatinib disodium)
Enrolling by invitation
- Warm Antibody Autoimmune Hemolytic Anemia
- Fostamatinib disodium
-
Los Angeles, California
- +36 more
Mar 2, 2022
Warm Antibody Autoimmune Hemolytic Anemia Trial in Worldwide (Fostamatinib disodium, Placebo)
Active, not recruiting
- Warm Antibody Autoimmune Hemolytic Anemia
- Fostamatinib disodium
- Placebo
-
Gilbert, Arizona
- +101 more
Nov 24, 2021
Warm Autoimmune Hemolytic Anemia Trial in Whittier (ALXN1830, Placebo)
Withdrawn
- Warm Autoimmune Hemolytic Anemia
- ALXN1830
- Placebo
-
Whittier, CaliforniaAlexion Study Site
Jul 9, 2020
Autoimmune Hemolytic Anemia, Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia Trial in Beijing (combination of a
Recruiting
- Autoimmune Hemolytic Anemia
- Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia
- combination of a single dose anti-CD20 antibody and bortezomib
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 12, 2021
Autoimmune Hemolytic Anemia Trial in Pessac (Interleukine-2)
Completed
- Autoimmune Hemolytic Anemia
-
Pessac, Aquitaine, FranceCHU de Bordeaux Hôpital Haut Lévêque
Feb 15, 2019
Immune Thrombocytopenia, Warm Autoimmune Hemolytic Anemia Trial in Créteil (Ninlaro)
Withdrawn
- Immune Thrombocytopenia
- Warm Autoimmune Hemolytic Anemia
-
Créteil, FranceMahevas
Oct 25, 2019
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune Trial in TianJin (levamisole, Prednisone)
Unknown status
- Anemia
- +7 more
-
TianJin, Tianjin, ChinaBlood Diseases Hospital Chinese Academy of Medical Sciences
Apr 18, 2012
Autoimmune Hemolytic Disease (Cold Type) (Warm Type) Trial in MIlan, Milan (prednisone, low dose rituximab)
Completed
- Autoimmune Hemolytic Disease (Cold Type) (Warm Type)
- prednisone, low dose rituximab
-
MIlan, Italy
- +1 more
Apr 29, 2011